CytarabineAntineoplastic AgentsDaunorubicinIdarubicinLeukemia, Myeloid, AcuteAntineoplastic Combined Chemotherapy ProtocolsAntimetabolites, AntineoplasticRemission InductionMitoxantroneConsolidation ChemotherapyEtoposideArabinonucleosidesLeukemia, MyeloidAntibiotics, AntineoplasticDrug Administration ScheduleMethotrexateVincristineDoxorubicinThioguanineTreatment Outcome6-MercaptopurineInduction ChemotherapyCyclophosphamideAntineoplastic Agents, PhytogenicPrecursor Cell Lymphoblastic Leukemia-LymphomaCarmustineDrug Screening Assays, AntitumorAmsacrineMeningeal CarcinomatosisInjections, SpinalLeukemic InfiltrationDrug Resistance, NeoplasmDose-Response Relationship, DrugLymphoma, Non-HodgkinDrug SynergismCytidine MonophosphateAcute DiseaseSurvival AnalysisCell Line, TumorAsparaginaseDrug AgonismNeoplasmsDisease-Free SurvivalApoptosisDeoxycytidine KinaseLeukemia, Myelomonocytic, AcuteArabinonucleotidesSurvival RateAntineoplastic Agents, AlkylatingLeukemiaLeukemia, Myeloid, Accelerated PhaseCisplatinTumor Cells, CulturedRecurrenceCentral Nervous System NeoplasmsMelphalanDexamethasoneDrug EvaluationSalvage TherapyVidarabineCombined Modality TherapyArabinofuranosylcytosine TriphosphateTransplantation, AutologousInfusions, IntravenousLeukemia, Myelogenous, Chronic, BCR-ABL PositiveCell SurvivalHL-60 CellsLeukemia P388TeniposideAnemia, Refractory, with Excess of BlastsMyelodysplastic SyndromesPhospholipid EthersPiperazinesEllipticinesGalliumAzacitidineBryostatinsThiadiazinesGloves, ProtectiveMeningitisBenzamidesPrognosisLymphomaPodophyllotoxinBleomycinCladribineLeukemia, Myeloid, Chronic-PhaseCell ProliferationPyrimidinesBlast CrisisAnthracyclinesAdenine NucleotidesAmaryllidaceae AlkaloidsPrednisoneDioxolanesLomustineNarcissusAster PlantPolyradiculopathyHarringtonines